Lab Members

Principal Investigator

Dr. Parsons’ research has helped to characterize the genetic landscapes of a variety of cancers, including the first identification of IDH1 and IDH2 as critical genes in brain tumors affecting both children and adults (gliomas). His current research primarily focuses on the clinical application of genomic technologies in pediatric cancer care and “precision oncology” strategies for the diagnosis and treatment of children with relapsed and refractory cancers.


Bioinformatics Analyst